CC BY-NC-ND 4.0 · Journal of Health and Allied Sciences NU 2014; 04(01): 046-051
DOI: 10.1055/s-0040-1703730
Original Article

SCREENING OF SELECTED PLANT ESSENTIAL OILS FOR THEIR ANTIFUNGAL ACTIVITY AGAINST CANDIDA SPECIES ISOLATED FROM DENTURE STOMATITIS PATIENTS

Vinaya Bhat
1  PhD Research Scholar, Department of Prosthodontics, A B Shetty Memorial Institute of Dental Sciences, Nitte University, Mangalore, India
,
S.M. Sharma
2  HOD, Professor & PhD Guide, Department of Oral & Maxillofacial Surgery, A B Shetty Memorial Institute of Dental Sciences,Nitte University, Mangalore, India
,
Veena Shetty
3  Co-Guide, Department of Microbiology, K. S. Hegde Medical Academy, Nitte University, Mangalore, India
,
C.S. Shastry
4  Principal & Co-Guide, Department of Pharmacognosy, NGSM Institute of Pharmaceutical Sciences, Nitte University, Mangalore, India
,
Vaman Rao
5  Co-Guide, Department of Biosciences, NMAM Institute of Technology, Nitte, Mangalore, India
,
Shilpa M. Shenoy
6  PhD Research Scholar, Department of Microbiology, K. S. Hegde Medical Academy, Mangalore, India
,
Santanu Saha
7  Senior Lecturer, Department of Pharmacognosy, NGSM Institute of Pharmaceutical Sciences, Nitte University, Mangalore, India
,
Sriram Balaji
8  PG Student, Department of Prosthodontics, A B Shetty Memorial Institute of Dental Sciences, Mangalore, India
› Author Affiliations

Abstract:

Background: Many efforts have been made to discover new antimicrobial compounds from various sources such as micro-organisms, animals and plants. Use of herbal medicines has a long history in Asian population in treating different ailments. Many plants have been found to have properties like antibacterial, antifungal and antioxidant activities.

In a complete denture wearer, due to either local or systemic factors, denture stomatitis has been found to a have high prevalence. In such patients, higher incidence of Candida infection and increased levels of Candida spp. also have been identified. Existing antifungal agents like Nystatin & Fluconazole have been found to have toxic effects on long term application and chances of development of drug resistance is high. Medicinal plants have been used to inhibit growth and development of fungal infection from Candida isolated from sites other than oral cavity.

Objectives: To evaluate the antifungal activity of some of the medicinal essential oils against oral isolates of Candida obtained from denture wearing patients identified through a survey.

Materials and Methods: The oral isolates of Candida species were collected after conducting a survey of complete denture wearers, wearing the denture for at least more than a year. The speciation of the organism was done after identifying it from the specimens. It was confirmed with the help of germ tube test, other biochemical tests and chlamydospore formation tests. A lab isolate also was included in the study. The essential oils of different herbs were extracted using hydro distillation methods. The antifungal activity of these oils was tested and compared with antifungal activity of Nystatin and fluconazole using modified Kirby-Baeur method. The inhibition zones of different oils were measured and compared among themselves against all the clinical isolates and the lab isolate.

Results: About 55 complete denture wearing patients have been surveyed and among them 27 have been found to be positive for Candida-associated denture stomatitis. Among the Candida species, Candida albicans was more prevalent followed by C. tropicalis and C. glabrata.

Among the test essential oils, Origanum vulgare (stored & fresh) and clove oil gave positive results against all isolates. The fresh samples gave better results than the stored and all three oils showed more antifungal activity than Nystatin & fluconazole.

Interpretation: The candida-associated denture stomatitis is prevalent in patients who are wearing denture prosthesis for more than a year.

Candida albicans is the most prevalent causative species followed by C. tropicalis and C. glabrata.

Origanum vulgare and clove oil are potent antifungal agents against oral species of Candida. They can be either used separately or their synergistic activity could be explored against denture stomatitis.



Publication History

Publication Date:
24 April 2020 (online)

© .

Thieme Medical and Scientific Publishers Private Ltd.
A-12, Second Floor, Sector -2, NOIDA -201301, India

 
  • References:

  • 1 Kebe K, Morii K, Matsuda Kk, Hata K, Nokubi T. Journal of Oral Rehabilitation 2006;33:36–42.
  • 2 Liu X, Hua H. Oral Manifestation of Chronic Mucocutaneous Candidiasis: Seven Case Reports. J oral Pathol Med 2007;36:528-32.
  • 3 Pereira-cenci T, Del bel cury AA, Crielaard W, Ten cate JM. Development of Candida-associated Denture Stomatitis: New Insights. J Appl Oral Sci. 2008;16:86-945.
  • 4 Williams D, Lewis M. Pathogenesis and treatment of oral candidosis. Journal of Oral Microbiology 2011:3.
  • 5 Emami E, Taraf H, Grandmont P, Gauthier G, Koninck L, Lamarche C, de.Souza R. The association of Denture Stomatitis and Partial Removable dental Prostheses: A Systematic Review. Int J Prosthodont 2012;25:113-9.
  • 6 Sanita PV, Pavarina AC, Eunice TG, Silva MM, Mima EGO, Ribeiro DG, Vergani CE. Candida spp. prevalence in well controlled type 2 diabetic patients with denture stomatitis. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2011;111:726-33
  • 7 Dangi YS, Soni ML, Namdeo KP. Oral Candidiasis: A Review. International Journal of Pharmacy and Pharmaceutical Sciences; 2010; 2(4).
  • 8 Dongari-Bagtzoglou A et al. Oral Candida Infection and Colonization in Solid Organ Transplant Recipients. Oral Microbiol Immunol 2009;24:249-54.
  • 9 Olczak-Kowalczyk D et al. Oral Candidiasis in Immunosuppressed Children and Young Adults after Liver or Kidney Transplantation. Pediatric Dent 2010;32:189-94.
  • 10 Reichart PA, Samaranayake LP, Bendick Ch, Schmidt-Westhausen M, Jayalathike MS. Prevalence of Oral Candida Species in Leprosy Patients from Cambodia and Thailand. J Oral Pathol Med 2007;36:342-6.
  • 11 Samaranayake, LP et al. Fungal Infections associated with HIV Infection. Oral Diseases. 2002;2:151-60.
  • 12 Sashikumar R, Kannan R. Salivary Glucose Levels and Oral Candidal Carriage in Type II Diabetics. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2010;109:706-711.
  • 13 Scully C,El-Kabir M, Samaranayake LP. Candida and Oral Candidosis: A Review. Critical Reviews in Oral Biology and Medicine,1994;5:125-157.
  • 14 Thompson GR et al. Oropharyngeal candidiasis in the era of antiretroviral therapy. Oral Surg Oral Med Oral Pathol Oral Radiol endod 2010;109:488-95.
  • 15 Witzel AL, Pires MFC, Carli ML, Rabelo GD, Nunes TB. Candida albicans isolation from Buccal Mucosa of Patients with HIV wearing removable dental prostheses. Int J Prosthodont 2012;25:127-131.
  • 16 Javidnia K, Miri R, Assadollahi M, Gholami M, Ghaderi M. Screening of selected plants growing in Iran for antimicrobial activity. Iranian Journal of Science & Technology, Transaction A.2009;33:329-333
  • 17 Rosato A, Vitali C, Piarulli M, Mazzotta M, Argentieri MP, Rosanna M. In vitro efficacy of the combination of Nystatin with the essential oils of Origanum vulgare and Pelargonium graveolens against some Candida species. International Journal of Phytotherapy & amp:Phytopharamacology. 2009;Elsevier.
  • 18 Stiles JC, Sparks W, Ronzio RA. The Inhibition of Candida albicans by Oregano. J of Applied Nutrition 1995;47:4:1-7.
  • 19 Manohar V, Ingram C, Gray J, Talpur NA, Echard BW, Bagchi D et al. Antifungal Activities of Origanum oil against Candida albicans. Molecular and Cellular Biochemistry. 2001;228:111-117.
  • 20 Cleff MB, Meinerz AR, Xavier M, Schuch LF, Meireles MCA, Rodrigues MRA et al. In Vitro activity of Origanum vulgare essential oil against Candida species. Braz. J. Microbiol. 2010;41(1).
  • 21 Webb BC, Thomas CJ, Willcox MD, Harty DW, Knox KW. Candidaassociated denture stomatitis. Aetiology and management: a review. Part 2. Oral diseases caused by Candida species. Aust Dent J. 1998;43:160-6.
  • 22 Salerno C, Pascale M, Contaldo M, Esposito V, Busciolano, Milillo L, Guida A, Petruzzi M, Serpico R. Candida-associated denture stomatitis. Oral Med and Pathol. 2010.
  • 23 Belazi M, Velegraki A, Fleva A, Gidarakou I, Papanaum L, Baka D, et al. Candidal overgrowth in diabetic patients: Potential predisposing factors. Mycoses 2005;48:192-6.
  • 24 Khosravi AR, Yarahmadi S, Baiat M, Shokri H, Pourkabireh M. Factors affecting the prevalence of yeasts in the oral cavity of patients with diabetes mellitus. J Mycol Med 2008;18:83-8.
  • 25 Goncalves RH, Miranda ET, Zaia JE, Giannini MJ. Species diversity of yeast in oral colonization of insulin-treated diabetes mellitus patients. Mycopathologia 2006;162:83-9,
  • 26 Li L, Jtunistic pathogen. J Dent Res 2007;86:204-15.
  • 27 Redding SW, Kirkpatrick WR, Dib O, Fothergill AW, Rinaldi MG, Patterson T. The epidemiology of non-albicans Candida in oropharyngeal candidiasis in, HIV patients. Spec Care Dentist 2000;20:178-81.
  • 28 Redding SW, Kirkpatrick WR, Coco BJ, et al. Candida glabrata oropharyngeal candidiasis in patients receiving radiation treatment for head and neck cancer. J Clin Microbiol 2002;40:1879-81.
  • 29 Coco BJ, Bagg J, Cross LJ, Jose A, Cross J, Ramage G. Mixed Candida albicans and Candida glabrata populations associated with pathogenesis of denture stomatitis. Oral Microbiol Immunol 2008;23:377-83
  • 30 Silva S, Henriques M. Hayes A, Oliveira R, Azeredo J, Williams DW. Candida glabrata and Candida albicans co-infection of an in vitro oral epithelium. J Oral Pathol Med. 2011;40:421-27
  • 31 Charlier C et al. Fluconazole for the management of invasive candidiasis: where do we stand after 15 years?.J of Antimicrobial Chemotherapy, 2006;57:384-410.
  • 32 Jafari-nodoushan AA, Kazemi A, Mirzaii F, Dehghani M. Fluconazole Susceptibility Profile of Candida isolates Recovered from Patients Specimens Admitted to yard Central Laboratory. Iranian J of Pharmaceutical Research 2008,7:69-75.
  • 33 Martin MV. The Use of Fluconazole and Itraconazole in the Treatment of Candida albicans Infections: a Review. J of Antimicrobial Chemotherapy 1999;44:429-37.
  • 34 Sheehan DJ, Hitchcock CA, Sibley CM. Current and Emerging Azole Antifungal Agents. Clin Microbiol Rev 1999;12:40-79.
  • 35 Wu T, Wright K, Hurst SF, Morrison CJ. Enhanced extracellular Production of Aspartyl Proteinase, a virulence factor, by C. albicans isolates following growth in subinhibitory concentrations of fluconazole. Antimicrobial Agents and Chemotherapy. 2000;44:1200-1208.
  • 36 Malabadi RB, Kumar SV. Assessment of Antifungal Activity of Some Medicinal Plants. Intl. J of Pharmacology.2007;3:499-504.
  • 37 Meena AK et al. Review on antifungal activities of Ayurvedic Medicinal Plants. Drug Invention Today. 2009;2:146-48.
  • 38 Hammer KA, Carson CF, Riley TV. Antimicrobial activity of essential oils and other plant extracts. Journal of Applied Microbiology 1999;86:985-990.
  • 39 Pfaller MA, Barry AL. Evaluation of a Novel Colorimetric Broth Micro dilution Method for Antifungal Susceptibility Testing of Yeast Isolates. J of Clinical Microbiology, Aug.1994;32:1992-96.
  • 40 Taxon: Origanum vulgare L. GRIN Taxonomy for Plants. United States Dept. of Agriculture.